235 related articles for article (PubMed ID: 30920708)
21. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants.
Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Apr; 27(4):421-31. PubMed ID: 12657926
[TBL] [Abstract][Full Text] [Related]
22. Ossifying fibromyxoid tumor: report of a case with cytomorphologic description.
Ahmed OI; Qasem SA; Salih ZT
Diagn Cytopathol; 2015 Aug; 43(8):646-9. PubMed ID: 25914177
[TBL] [Abstract][Full Text] [Related]
23. Novel MEAF6-SUZ12 fusion in ossifying fibromyxoid tumor with unusual features.
Killian K; Leckey BD; Naous R; McGough RL; Surrey LF; John I
Genes Chromosomes Cancer; 2021 Sep; 60(9):631-634. PubMed ID: 33840146
[TBL] [Abstract][Full Text] [Related]
24. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
[TBL] [Abstract][Full Text] [Related]
25. Atypical and malignant variants of ossifying fibromyxoid tumor. Clinicopathologic analysis of six cases.
Kilpatrick SE; Ward WG; Mozes M; Miettinen M; Fukunaga M; Fletcher CD
Am J Surg Pathol; 1995 Sep; 19(9):1039-46. PubMed ID: 7661277
[TBL] [Abstract][Full Text] [Related]
26. Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.
Thway K; Chisholm J; Hayes A; Swansbury J; Fisher C
Hum Pathol; 2015 Mar; 46(3):461-6. PubMed ID: 25532939
[TBL] [Abstract][Full Text] [Related]
27. Ossifying fibromyxoid tumor: Fine-needle aspiration cytology findings of a rare soft tissue neoplasm.
Kumari N; Anthony ML; Durgapal P; Joshi PP; Rajput D; Singh A
Diagn Cytopathol; 2020 Apr; 48(4):396-400. PubMed ID: 31925994
[TBL] [Abstract][Full Text] [Related]
28. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
29. Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(2):2139-45. PubMed ID: 25973116
[TBL] [Abstract][Full Text] [Related]
30. Ossifying Fibromyxoid Tumor of the Retromolar Trigone: A Case Report and Systematic Review of the Literature.
Titsinides S; Nikitakis NG; Tasoulas J; Daskalopoulos A; Goutzanis L; Sklavounou A
Int J Surg Pathol; 2017 Sep; 25(6):526-532. PubMed ID: 28436288
[TBL] [Abstract][Full Text] [Related]
31. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
33. Ossifying Fibromyxoid Tumor: A Review With Emphasis on Recent Molecular Advances and Differential Diagnosis.
Carter CS; Patel RM
Arch Pathol Lab Med; 2019 Dec; 143(12):1504-1512. PubMed ID: 31765250
[TBL] [Abstract][Full Text] [Related]
34. A distinctive subset of PEComas harbors TFE3 gene fusions.
Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
[TBL] [Abstract][Full Text] [Related]
35. Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung.
Agaimy A; Stoehr R; Michal M; Christopoulos P; Winter H; Zhang L; Stenzinger A; Michal M; Mechtersheimer G; Antonescu CR
Am J Surg Pathol; 2021 Nov; 45(11):1541-1549. PubMed ID: 33899786
[TBL] [Abstract][Full Text] [Related]
36. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract][Full Text] [Related]
37. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
38. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
[TBL] [Abstract][Full Text] [Related]
39. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
Lee SJ; Yang WI; Chung WS; Kim SK
Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
[TBL] [Abstract][Full Text] [Related]
40. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
